51 citations as recorded by crossref.

1. Global practice variation of suppressive antimicrobial treatment for prosthetic joint infections: A cross-sectional survey study J. Hanssen et al. 10.1016/j.jinf.2024.106316
2. Chronic Suppressive Antibiotic Treatment for Staphylococcal Bone and Joint Implant–Related Infections G. Ceccarelli et al. 10.3390/antibiotics12050937
3. Candida periprosthetic infection of the hip: a systematic review of surgical treatments and clinical outcomes F. Fusini et al. 10.1007/s00264-019-04369-z
4. Proactive Therapeutic Drug MONiToring to Guide Suppressive Antibiotic Therapy with DALBAvaNcin ( > 12 weeks) in Osteoarticular Infections (MONTALBANO) C. Mariani et al. 10.5194/jbji-10-255-2025
5. Suppressive antibiotic therapy in prosthetic joint infections: a multicentre cohort study R. Escudero-Sanchez et al. 10.1016/j.cmi.2019.09.007
6. Predictors of Success With Chronic Antibiotic Suppression for Prosthetic Joint Infections R. Burr et al. 10.1016/j.arth.2022.02.003
7. Long-term antimicrobial suppression prevents treatment failure of streptococcal periprosthetic joint infection N. Renz et al. 10.1016/j.jinf.2019.06.015
8. Risikofaktoren und Managementstrategien des Früh- und Spätinfektes nach Rekonstruktion mit Tumorspezialendoprothesen V. Janz et al. 10.1007/s00132-020-03872-1
9. Candida periprosthetic infection of the knee: a systematic review of surgical treatments and clinical outcomes F. Fusini et al. 10.1007/s00590-022-03224-z
10. Predicting Success of Two-Stage Exchange for Prosthetic Joint Infection Using C-Reactive Protein/Albumin Ratio C. Hong et al. 10.1155/2019/6521941
11. The efficacy of suppressive antibiotic treatment in patients managed non-operatively for periprosthetic joint infection and a draining sinus K. Lensen et al. 10.5194/jbji-6-313-2021
12. Peri-Prosthetic Joint Infection in Patients Prescribed Suppressive Antibiotic Therapy Undergoing Primary Total Joint Arthroplasty: A 1:4 Case Control Matched Study T. Humphrey et al. 10.1089/sur.2022.261
13. Prosthetic Joint Infection in Mega-Arthroplasty Following Shoulder, Hip and Knee Malignancy—A Prospective Follow-Up Study T. Khakzad et al. 10.3390/life12122134
14. Prolonged suppressive antibiotic therapy is successful in the management of prosthetic joint infection N. Sandiford et al. 10.1007/s00590-019-02559-4
15. Genomic characterization of beta‐haemolytic streptococci isolated from prosthetic joint infections N. Löwbeer et al. 10.1111/apm.13299
16. Dosing and treatment duration of suppressive antimicrobial therapy in orthopedic implant infections: a cohort study J. Hanssen et al. 10.5194/jbji-9-149-2024
17. Self-Resolution of a Draining Sinus Tract in a Patient with Chronic Periprosthetic Hip Infection T. Shelton et al. 10.1155/2018/8657562
18. Unraveling the Challenges: A Compelling Case of Staph Meningitis and Graft Infection in a Bovine Brain Graft Recipient S. Ahmed et al. 10.7759/cureus.64806
19. Dalbavancin as suppressive antibiotic therapy in patients with prosthetic infections: efficacy and safety A. Ruiz-Sancho et al. 10.3389/fphar.2023.1185602
20. Orthopaedic Implant-Associated Staphylococcal Infections: A Critical Reappraisal of Unmet Clinical Needs Associated with the Implementation of the Best Antibiotic Choice M. Gatti et al. 10.3390/antibiotics11030406
21. Medical innovations to maintain the function in patients with chronic PJI for whom explantation is not desirable: a pathophysiology-, multidisciplinary-, and experience-based approach T. Ferry et al. 10.1051/sicotj/2020021
22. Oral tetracyclines for bone and joint infections: what do we know? T. Cartau et al. 10.5194/jbji-10-143-2025
23. Pharmacotherapy options and drug development in managing periprosthetic joint infections in the elderly A. Macias-Valcayo et al. 10.1080/14656566.2019.1602118
24. Résultats de l’intervention de Girdlestone pour le traitement de l’infection réfractaire sur prothèse de hanche A. Sabelle et al. 10.1016/j.rcot.2025.06.003
25. Suppressive Antibiotic Therapy After Debridement, Antibiotics, and Implant Retention is Well-Tolerated Without Inducing Resistance: A Multicenter Study S. Nandi et al. 10.1016/j.arth.2023.09.004
26. Research progress of asymptomatic bacteriuria before arthroplasty Q. Zhang et al. 10.1097/MD.0000000000009810
27. Chronic prosthetic joint infections with a draining sinus. Who should receive suppressive antibiotic treatment? K. Lensen et al. 10.5194/jbji-6-43-2020
28. Salvage-Optionen bei persistierendem Infekt nach Knietotalendoprothese E. Röhner & G. Matziolis 10.1007/s43205-021-00121-z
29. Is there a place for oral antibiotics in treating prosthetic joint infections in patients in whom surgery is contraindicated? M. Downs et al. 10.1097/EBP.0000000000000996
30. Past and Future of Phage Therapy and Phage-Derived Proteins in Patients with Bone and Joint Infection T. Ferry et al. 10.3390/v13122414
31. Outcomes of Long-Term Antibiotic Therapy for Prosthetic Joint Infection: A Cohort Study in a Canadian High-Volume Arthroplasty Center C. Righolt et al. 10.1016/j.artd.2025.101789
32. Arthroscopic “Debridement and Implant Retention” With Local Administration of Exebacase (Lysin CF-301) Followed by Suppressive Tedizolid as Salvage Therapy in Elderly Patients for Relapsing Multidrug-Resistant S. epidermidis Prosthetic Knee Infection T. Ferry et al. 10.3389/fmed.2021.550853
33. Clinical use of linezolid in periprosthetic joint infections – a systematic review C. Theil et al. 10.5194/jbji-6-7-2020
34. Long-Term Impact of Suppressive Antibiotic Therapy on Intestinal Microbiota R. Escudero-Sánchez et al. 10.3390/genes12010041
35. Contemporary Prosthetic Joint Infection Management: Is There a Role for Suppressive Antibiotic Therapy? N. Sandiford & D. Kendoff 10.1016/j.artd.2021.06.012
36. Periprosthetic Joint Infection R. Miller et al. 10.2106/JBJS.RVW.19.00224
37. How to manage treatment failure in prosthetic joint infection T. Peel & R. de Steiger 10.1016/j.cmi.2020.06.022
38. Debridement, antibiotics and implant retention: are all approaches to periprosthetic joint infection equal? Same procedures, different outcomes P. Sendi et al. 10.1016/j.cmi.2025.04.037
39. Adverse Events Associated with Prolonged Antibiotic Therapy for Periprosthetic Joint Infections—A Prospective Study with a Special Focus on Rifampin P. Reinecke et al. 10.3390/antibiotics12111560
40. Suppressive Antibiotic Therapy in Prosthetic Joint Infections: A Contemporary Overview H. Harrabi et al. 10.3390/antibiotics14030277
41. One-Stage Implant-Retaining Revision for Simultaneous Bilateral Infected Total Knee Arthroplasty: A Report of a Rare Case N. Wirries et al. 10.1155/2021/8846198
42. The Sinus Tract in Bone and Joint Infection: Minimally Invasive Salvation or Prolonged Suffering? A Multicenter Study S. Klim et al. 10.3390/jpm13050737
43. Complications of Hip Hemiarthroplasty G. Domingue et al. 10.3928/01477447-20230125-06
44. Surgical strategies for management of infection following knee arthroplasty and arthroscopic procedures A. Alvand et al. 10.1016/j.mporth.2019.03.003
45. Suppressive Antibiotic Treatment in Prosthetic Joint Infections: A Perspective J. Cobo & R. Escudero-Sanchez 10.3390/antibiotics10060743
46. Current Insights in the Evaluation and Treatment of Infected Total Knee Arthroplasty B. Ashley & J. Parvizi 10.1055/s-0041-1737030
47. Proceedings from the 2018 International Consensus Meeting on Orthopedic Infections: management of periprosthetic shoulder infection G. Garrigues et al. 10.1016/j.jse.2019.04.015
48. Infected total hip replacements: assessment and management H. Matar et al. 10.12968/hmed.2018.79.5.265
49. Clinical Outcome of Antibiotic Suppressive Therapy in Patients with a Prosthetic Joint Infection after Hip Replacement B. Leijtens et al. 10.7150/jbji.37262
50. The Use of Long-term Antibiotics for Suppression of Bacterial Infections M. Horne et al. 10.1093/cid/ciae302
51. Results of the Girdlestone Procedure for the Treatment of Refractory Hip Prosthesis Infections A. Sabelle et al. 10.1016/j.otsr.2025.104313